Quality of Head & Neck Cancer Care

At the Cedars-Sinai Head & Neck Cancer Program, each patient is treated as an individual and provided with specialized care.

Complex cases are presented at the Head and Neck Tumor Board to help physicians consider all the factors involved. On this basis, the team creates a treatment plan designed to preserve the best quality of life for each patient.

Physicians at the Head and Neck Cancer Program are highly experienced at treating common cases as well as difficult cases of head and neck cancer. They specialize in minimally invasive surgery to treat head and neck tumors, as well as thyroid and parathyroid conditions. Transoral laser microsurgery, as well as transoral robotic surgery, has been found to preserve normal tissue, cause less pain, and help maintain speech and swallowing.

Our physicians are members of professional organizations such as the American Head and Neck Society, the American Society for Therapeutic Radiology and Oncology, and the American Society of Clinical Oncology.
 

Measuring the Quality of Care at the Cedars-Sinai Head & Neck Cancer Program

To continually improve upon the care given to patients at the Cedars-Sinai Head and Neck Cancer Program of Excellence, a number of factors that lead to a high quality of care are monitored. These outcomes are compared to the expected outcomes, if available, for a clinically similar patient population.  These measures include:

  • Case Volume: The number of patients treated, including new patients
  • Length of Stay: The length of stay  is the number of actual days the patient was hospitalized.
  • Survival:The percentage of patients who were discharged alive.
  • 30 Day Readmission: These data exclude admissions for chemotherapy, radiation therapy rehabilitation, dialysis, labor and delivery, death, and first time admissions.

The information is made available by he University HealthSystem Consortium (UHC), an alliance of more than 300 of the nation’s non-profit academic medical centers and their affiliated hospitals.  The majority of these facilities participate in UHC's Clinical DataBase/Resource Manager, which was accessed on accessed on April 7, 2015 to provide the information below for head or neck cancer patients discharged between January 2014 and December 2014.

Volume Statistics

Cedars-Sinai Head & Neck Cancer ProgramAll Inpatient CasesNew Patients in 2014Increase over Prior Year
For patients with a diagnosis of Head or Neck Cancer,  
excluding Thyroid Cancer
16295*90%*

 

Outcome Measures

The data below reflects outcomes for the 162 inpatients treated in 2014.

Cedars-Sinai Head & Neck Cancer ProgramLength of StayPatient Survival 330 Day Readmission Rate
Cedars-
Sinai
ExpectedCedars-
Sinai
ExpectedCedars-
Sinai
Expected
For patients with a diagnosis of Head or Neck Cancer,  excluding Thyroid Cancer5.25.793.8%93.9%5.3%not available

 

 *Source: National Cancer Registry.

Android app on Google Play